世界のインターフェロンバイオシミラー市場インサイト及び予測(~2026年)

【英語タイトル】Global Interferon Biosimilar Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV01774)・商品コード:QYR20NV01774
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはインターフェロンバイオシミラーの世界市場について調査・分析した資料です。種類別(持続性タイプ、普通タイプ)の市場規模、用途別(C型肝炎、B型肝炎、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別インターフェロンバイオシミラーの競争状況、市場シェア
・世界のインターフェロンバイオシミラー市場:種類別市場規模 2015年-2020年(持続性タイプ、普通タイプ)
・世界のインターフェロンバイオシミラー市場:種類別市場規模予測 2021年-2026年(持続性タイプ、普通タイプ)
・世界のインターフェロンバイオシミラー市場:用途別市場規模 2015年-2020年(C型肝炎、B型肝炎、その他)
・世界のインターフェロンバイオシミラー市場:用途別市場規模予測 2021年-2026年(C型肝炎、B型肝炎、その他)
・北米のインターフェロンバイオシミラー市場分析:米国、カナダ
・ヨーロッパのインターフェロンバイオシミラー市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのインターフェロンバイオシミラー市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のインターフェロンバイオシミラー市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのインターフェロンバイオシミラー市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Roche、Biosidus、Zydus Cadila、Nanogen、Amega Biotech、Rhein Minapharm Biogenetics、PROBIOMED、3sbio、Amgen、Bayer、Schering Plough、Merck
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Interferon Biosimilar Market
The global Interferon Biosimilar market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Interferon Biosimilar Scope and Market Size
Interferon Biosimilar market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interferon Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Interferon Biosimilar market is segmented into
Long-lasting Type
Ordinary Type

Segment by Application, the Interferon Biosimilar market is segmented into
Hepatitis C
Hepatitis B
Other

Regional and Country-level Analysis
The Interferon Biosimilar market is analysed and market size information is provided by regions (countries).
The key regions covered in the Interferon Biosimilar market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Interferon Biosimilar Market Share Analysis
Interferon Biosimilar market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Interferon Biosimilar business, the date to enter into the Interferon Biosimilar market, Interferon Biosimilar product introduction, recent developments, etc.

The major vendors covered:
Roche
Biosidus
Zydus Cadila
Nanogen
Amega Biotech
Rhein Minapharm Biogenetics
PROBIOMED
3sbio
Amgen
Bayer
Schering Plough
Merck

【レポートの目次】

1 Study Coverage
1.1 Interferon Biosimilar Product Introduction
1.2 Market Segments
1.3 Key Interferon Biosimilar Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Interferon Biosimilar Market Size Growth Rate by Type
1.4.2 Long-lasting Type
1.4.3 Ordinary Type
1.5 Market by Application
1.5.1 Global Interferon Biosimilar Market Size Growth Rate by Application
1.5.2 Hepatitis C
1.5.3 Hepatitis B
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Interferon Biosimilar Market Size, Estimates and Forecasts
2.1.1 Global Interferon Biosimilar Revenue 2015-2026
2.1.2 Global Interferon Biosimilar Sales 2015-2026
2.2 Global Interferon Biosimilar, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Interferon Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Interferon Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Interferon Biosimilar Competitor Landscape by Players
3.1 Interferon Biosimilar Sales by Manufacturers
3.1.1 Interferon Biosimilar Sales by Manufacturers (2015-2020)
3.1.2 Interferon Biosimilar Sales Market Share by Manufacturers (2015-2020)
3.2 Interferon Biosimilar Revenue by Manufacturers
3.2.1 Interferon Biosimilar Revenue by Manufacturers (2015-2020)
3.2.2 Interferon Biosimilar Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Interferon Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Interferon Biosimilar Revenue in 2019
3.2.5 Global Interferon Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Interferon Biosimilar Price by Manufacturers
3.4 Interferon Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Interferon Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Interferon Biosimilar Product Type
3.4.3 Date of International Manufacturers Enter into Interferon Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Interferon Biosimilar Market Size by Type (2015-2020)
4.1.1 Global Interferon Biosimilar Sales by Type (2015-2020)
4.1.2 Global Interferon Biosimilar Revenue by Type (2015-2020)
4.1.3 Interferon Biosimilar Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Interferon Biosimilar Market Size Forecast by Type (2021-2026)
4.2.1 Global Interferon Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Interferon Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Interferon Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Interferon Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Interferon Biosimilar Market Size by Application (2015-2020)
5.1.1 Global Interferon Biosimilar Sales by Application (2015-2020)
5.1.2 Global Interferon Biosimilar Revenue by Application (2015-2020)
5.1.3 Interferon Biosimilar Price by Application (2015-2020)
5.2 Interferon Biosimilar Market Size Forecast by Application (2021-2026)
5.2.1 Global Interferon Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Interferon Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Interferon Biosimilar Price Forecast by Application (2021-2026)

6 North America
6.1 North America Interferon Biosimilar by Country
6.1.1 North America Interferon Biosimilar Sales by Country
6.1.2 North America Interferon Biosimilar Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Interferon Biosimilar Market Facts & Figures by Type
6.3 North America Interferon Biosimilar Market Facts & Figures by Application

7 Europe
7.1 Europe Interferon Biosimilar by Country
7.1.1 Europe Interferon Biosimilar Sales by Country
7.1.2 Europe Interferon Biosimilar Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Interferon Biosimilar Market Facts & Figures by Type
7.3 Europe Interferon Biosimilar Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Interferon Biosimilar by Region
8.1.1 Asia Pacific Interferon Biosimilar Sales by Region
8.1.2 Asia Pacific Interferon Biosimilar Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Interferon Biosimilar Market Facts & Figures by Type
8.3 Asia Pacific Interferon Biosimilar Market Facts & Figures by Application

9 Latin America
9.1 Latin America Interferon Biosimilar by Country
9.1.1 Latin America Interferon Biosimilar Sales by Country
9.1.2 Latin America Interferon Biosimilar Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Interferon Biosimilar Market Facts & Figures by Type
9.3 Central & South America Interferon Biosimilar Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Interferon Biosimilar by Country
10.1.1 Middle East and Africa Interferon Biosimilar Sales by Country
10.1.2 Middle East and Africa Interferon Biosimilar Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Interferon Biosimilar Market Facts & Figures by Type
10.3 Middle East and Africa Interferon Biosimilar Market Facts & Figures by Application

11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Interferon Biosimilar Products Offered
11.1.5 Roche Related Developments
11.2 Biosidus
11.2.1 Biosidus Corporation Information
11.2.2 Biosidus Description and Business Overview
11.2.3 Biosidus Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biosidus Interferon Biosimilar Products Offered
11.2.5 Biosidus Related Developments
11.3 Zydus Cadila
11.3.1 Zydus Cadila Corporation Information
11.3.2 Zydus Cadila Description and Business Overview
11.3.3 Zydus Cadila Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Zydus Cadila Interferon Biosimilar Products Offered
11.3.5 Zydus Cadila Related Developments
11.4 Nanogen
11.4.1 Nanogen Corporation Information
11.4.2 Nanogen Description and Business Overview
11.4.3 Nanogen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Nanogen Interferon Biosimilar Products Offered
11.4.5 Nanogen Related Developments
11.5 Amega Biotech
11.5.1 Amega Biotech Corporation Information
11.5.2 Amega Biotech Description and Business Overview
11.5.3 Amega Biotech Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amega Biotech Interferon Biosimilar Products Offered
11.5.5 Amega Biotech Related Developments
11.6 Rhein Minapharm Biogenetics
11.6.1 Rhein Minapharm Biogenetics Corporation Information
11.6.2 Rhein Minapharm Biogenetics Description and Business Overview
11.6.3 Rhein Minapharm Biogenetics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Rhein Minapharm Biogenetics Interferon Biosimilar Products Offered
11.6.5 Rhein Minapharm Biogenetics Related Developments
11.7 PROBIOMED
11.7.1 PROBIOMED Corporation Information
11.7.2 PROBIOMED Description and Business Overview
11.7.3 PROBIOMED Sales, Revenue and Gross Margin (2015-2020)
11.7.4 PROBIOMED Interferon Biosimilar Products Offered
11.7.5 PROBIOMED Related Developments
11.8 3sbio
11.8.1 3sbio Corporation Information
11.8.2 3sbio Description and Business Overview
11.8.3 3sbio Sales, Revenue and Gross Margin (2015-2020)
11.8.4 3sbio Interferon Biosimilar Products Offered
11.8.5 3sbio Related Developments
11.9 Amgen
11.9.1 Amgen Corporation Information
11.9.2 Amgen Description and Business Overview
11.9.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Amgen Interferon Biosimilar Products Offered
11.9.5 Amgen Related Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Description and Business Overview
11.10.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bayer Interferon Biosimilar Products Offered
11.10.5 Bayer Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Interferon Biosimilar Products Offered
11.1.5 Roche Related Developments
11.12 Merck
11.12.1 Merck Corporation Information
11.12.2 Merck Description and Business Overview
11.12.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Merck Products Offered
11.12.5 Merck Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Interferon Biosimilar Market Estimates and Projections by Region
12.1.1 Global Interferon Biosimilar Sales Forecast by Regions 2021-2026
12.1.2 Global Interferon Biosimilar Revenue Forecast by Regions 2021-2026
12.2 North America Interferon Biosimilar Market Size Forecast (2021-2026)
12.2.1 North America: Interferon Biosimilar Sales Forecast (2021-2026)
12.2.2 North America: Interferon Biosimilar Revenue Forecast (2021-2026)
12.2.3 North America: Interferon Biosimilar Market Size Forecast by Country (2021-2026)
12.3 Europe Interferon Biosimilar Market Size Forecast (2021-2026)
12.3.1 Europe: Interferon Biosimilar Sales Forecast (2021-2026)
12.3.2 Europe: Interferon Biosimilar Revenue Forecast (2021-2026)
12.3.3 Europe: Interferon Biosimilar Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Interferon Biosimilar Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Interferon Biosimilar Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Interferon Biosimilar Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Interferon Biosimilar Market Size Forecast by Region (2021-2026)
12.5 Latin America Interferon Biosimilar Market Size Forecast (2021-2026)
12.5.1 Latin America: Interferon Biosimilar Sales Forecast (2021-2026)
12.5.2 Latin America: Interferon Biosimilar Revenue Forecast (2021-2026)
12.5.3 Latin America: Interferon Biosimilar Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Interferon Biosimilar Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Interferon Biosimilar Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Interferon Biosimilar Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Interferon Biosimilar Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Interferon Biosimilar Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Interferon Biosimilar Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Interferon Biosimilar Market Segments
Table 2. Ranking of Global Top Interferon Biosimilar Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Interferon Biosimilar Market Size Growth Rate by Type 2020-2026 (Kiloton) & (US$ Million)
Table 4. Major Manufacturers of Long-lasting Type
Table 5. Major Manufacturers of Ordinary Type
Table 6. Global Interferon Biosimilar Market Size Growth Rate by Application 2020-2026 (Kiloton)
Table 7. Global Interferon Biosimilar Market Size by Region (Kiloton) & (US$ Million): 2020 VS 2026
Table 8. Global Interferon Biosimilar Sales by Regions 2015-2020 (Kiloton)
Table 9. Global Interferon Biosimilar Sales Market Share by Regions (2015-2020)
Table 10. Global Interferon Biosimilar Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Interferon Biosimilar Sales by Manufacturers (2015-2020) (Kiloton)
Table 12. Global Interferon Biosimilar Sales Share by Manufacturers (2015-2020)
Table 13. Global Interferon Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Interferon Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interferon Biosimilar as of 2019)
Table 15. Interferon Biosimilar Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Interferon Biosimilar Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Interferon Biosimilar Price (2015-2020) (US$/Ton)
Table 18. Interferon Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Interferon Biosimilar Product Type
Table 20. Date of International Manufacturers Enter into Interferon Biosimilar Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Interferon Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 23. Global Interferon Biosimilar Sales Share by Type (2015-2020)
Table 24. Global Interferon Biosimilar Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Interferon Biosimilar Revenue Share by Type (2015-2020)
Table 26. Interferon Biosimilar Average Selling Price (ASP) by Type 2015-2020 (US$/Ton)
Table 27. Global Interferon Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 28. Global Interferon Biosimilar Sales Share by Application (2015-2020)
Table 29. North America Interferon Biosimilar Sales by Country (2015-2020) (Kiloton)
Table 30. North America Interferon Biosimilar Sales Market Share by Country (2015-2020)
Table 31. North America Interferon Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Interferon Biosimilar Revenue Market Share by Country (2015-2020)
Table 33. North America Interferon Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 34. North America Interferon Biosimilar Sales Market Share by Type (2015-2020)
Table 35. North America Interferon Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 36. North America Interferon Biosimilar Sales Market Share by Application (2015-2020)
Table 37. Europe Interferon Biosimilar Sales by Country (2015-2020) (Kiloton)
Table 38. Europe Interferon Biosimilar Sales Market Share by Country (2015-2020)
Table 39. Europe Interferon Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Interferon Biosimilar Revenue Market Share by Country (2015-2020)
Table 41. Europe Interferon Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 42. Europe Interferon Biosimilar Sales Market Share by Type (2015-2020)
Table 43. Europe Interferon Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 44. Europe Interferon Biosimilar Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Interferon Biosimilar Sales by Region (2015-2020) (Kiloton)
Table 46. Asia Pacific Interferon Biosimilar Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Interferon Biosimilar Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Interferon Biosimilar Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Interferon Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 50. Asia Pacific Interferon Biosimilar Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Interferon Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 52. Asia Pacific Interferon Biosimilar Sales Market Share by Application (2015-2020)
Table 53. Latin America Interferon Biosimilar Sales by Country (2015-2020) (Kiloton)
Table 54. Latin America Interferon Biosimilar Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Interferon Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Interferon Biosimilar Revenue Market Share by Country (2015-2020)
Table 57. Latin America Interferon Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 58. Latin America Interferon Biosimilar Sales Market Share by Type (2015-2020)
Table 59. Latin America Interferon Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 60. Latin America Interferon Biosimilar Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Interferon Biosimilar Sales by Country (2015-2020) (Kiloton)
Table 62. Middle East and Africa Interferon Biosimilar Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Interferon Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Interferon Biosimilar Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Interferon Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 66. Middle East and Africa Interferon Biosimilar Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Interferon Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 68. Middle East and Africa Interferon Biosimilar Sales Market Share by Application (2015-2020)
Table 69. Roche Corporation Information
Table 70. Roche Description and Major Businesses
Table 71. Roche Interferon Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 72. Roche Product
Table 73. Roche Recent Development
Table 74. Biosidus Corporation Information
Table 75. Biosidus Description and Major Businesses
Table 76. Biosidus Interferon Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 77. Biosidus Product
Table 78. Biosidus Recent Development
Table 79. Zydus Cadila Corporation Information
Table 80. Zydus Cadila Description and Major Businesses
Table 81. Zydus Cadila Interferon Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 82. Zydus Cadila Product
Table 83. Zydus Cadila Recent Development
Table 84. Nanogen Corporation Information
Table 85. Nanogen Description and Major Businesses
Table 86. Nanogen Interferon Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 87. Nanogen Product
Table 88. Nanogen Recent Development
Table 89. Amega Biotech Corporation Information
Table 90. Amega Biotech Description and Major Businesses
Table 91. Amega Biotech Interferon Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 92. Amega Biotech Product
Table 93. Amega Biotech Recent Development
Table 94. Rhein Minapharm Biogenetics Corporation Information
Table 95. Rhein Minapharm Biogenetics Description and Major Businesses
Table 96. Rhein Minapharm Biogenetics Interferon Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 97. Rhein Minapharm Biogenetics Product
Table 98. Rhein Minapharm Biogenetics Recent Development
Table 99. PROBIOMED Corporation Information
Table 100. PROBIOMED Description and Major Businesses
Table 101. PROBIOMED Interferon Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 102. PROBIOMED Product
Table 103. PROBIOMED Recent Development
Table 104. 3sbio Corporation Information
Table 105. 3sbio Description and Major Businesses
Table 106. 3sbio Interferon Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 107. 3sbio Product
Table 108. 3sbio Recent Development
Table 109. Amgen Corporation Information
Table 110. Amgen Description and Major Businesses
Table 111. Amgen Interferon Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 112. Amgen Product
Table 113. Amgen Recent Development
Table 114. Bayer Corporation Information
Table 115. Bayer Description and Major Businesses
Table 116. Bayer Interferon Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 117. Bayer Product
Table 118. Bayer Recent Development
Table 119. Schering Plough Corporation Information
Table 120. Schering Plough Description and Major Businesses
Table 121. Schering Plough Interferon Biosimilar Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 122. Schering Plough Product
Table 123. Schering Plough Recent Development
Table 124. Merck Corporation Information
Table 125. Merck Description and Major Businesses
Table 126. Merck Interferon Biosimilar Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 127. Merck Product
Table 128. Merck Recent Development
Table 129. Global Interferon Biosimilar Sales Forecast by Regions (2021-2026) (Kiloton)
Table 130. Global Interferon Biosimilar Sales Market Share Forecast by Regions (2021-2026)
Table 131. Global Interferon Biosimilar Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 132. Global Interferon Biosimilar Revenue Market Share Forecast by Regions (2021-2026)
Table 133. North America: Interferon Biosimilar Sales Forecast by Country (2021-2026) (Kiloton)
Table 134. North America: Interferon Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Europe: Interferon Biosimilar Sales Forecast by Country (2021-2026) (Kiloton)
Table 136. Europe: Interferon Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Asia Pacific: Interferon Biosimilar Sales Forecast by Region (2021-2026) (Kiloton)
Table 138. Asia Pacific: Interferon Biosimilar Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Latin America: Interferon Biosimilar Sales Forecast by Country (2021-2026) (Kiloton)
Table 140. Latin America: Interferon Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Middle East and Africa: Interferon Biosimilar Sales Forecast by Country (2021-2026) (Kiloton)
Table 142. Middle East and Africa: Interferon Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Market Risks
Table 146. Main Points Interviewed from Key Interferon Biosimilar Players
Table 147. Interferon Biosimilar Customers List
Table 148. Interferon Biosimilar Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Interferon Biosimilar Product Picture
Figure 2. Global Interferon Biosimilar Sales Market Share by Type in 2020 & 2026
Figure 3. Long-lasting Type Product Picture
Figure 4. Ordinary Type Product Picture
Figure 5. Global Interferon Biosimilar Sales Market Share by Application in 2020 & 2026
Figure 6. Hepatitis C
Figure 7. Hepatitis B
Figure 8. Other
Figure 9. Interferon Biosimilar Report Years Considered
Figure 10. Global Interferon Biosimilar Market Size 2015-2026 (US$ Million)
Figure 11. Global Interferon Biosimilar Sales 2015-2026 (Kiloton)
Figure 12. Global Interferon Biosimilar Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Interferon Biosimilar Sales Market Share by Region (2015-2020)
Figure 14. Global Interferon Biosimilar Sales Market Share by Region in 2019
Figure 15. Global Interferon Biosimilar Revenue Market Share by Region (2015-2020)
Figure 16. Global Interferon Biosimilar Revenue Market Share by Region in 2019
Figure 17. Global Interferon Biosimilar Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Interferon Biosimilar Revenue in 2019
Figure 19. Interferon Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Interferon Biosimilar Sales Market Share by Type (2015-2020)
Figure 21. Global Interferon Biosimilar Sales Market Share by Type in 2019
Figure 22. Global Interferon Biosimilar Revenue Market Share by Type (2015-2020)
Figure 23. Global Interferon Biosimilar Revenue Market Share by Type in 2019
Figure 24. Global Interferon Biosimilar Market Share by Price Range (2015-2020)
Figure 25. Global Interferon Biosimilar Sales Market Share by Application (2015-2020)
Figure 26. Global Interferon Biosimilar Sales Market Share by Application in 2019
Figure 27. Global Interferon Biosimilar Revenue Market Share by Application (2015-2020)
Figure 28. Global Interferon Biosimilar Revenue Market Share by Application in 2019
Figure 29. North America Interferon Biosimilar Sales Growth Rate 2015-2020 (Kiloton)
Figure 30. North America Interferon Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Interferon Biosimilar Sales Market Share by Country in 2019
Figure 32. North America Interferon Biosimilar Revenue Market Share by Country in 2019
Figure 33. U.S. Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 34. U.S. Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 36. Canada Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Interferon Biosimilar Market Share by Type in 2019
Figure 38. North America Interferon Biosimilar Market Share by Application in 2019
Figure 39. Europe Interferon Biosimilar Sales Growth Rate 2015-2020 (Kiloton)
Figure 40. Europe Interferon Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Interferon Biosimilar Sales Market Share by Country in 2019
Figure 42. Europe Interferon Biosimilar Revenue Market Share by Country in 2019
Figure 43. Germany Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 44. Germany Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 46. France Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 48. U.K. Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 50. Italy Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 52. Russia Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Interferon Biosimilar Market Share by Type in 2019
Figure 54. Europe Interferon Biosimilar Market Share by Application in 2019
Figure 55. Asia Pacific Interferon Biosimilar Sales Growth Rate 2015-2020 (Kiloton)
Figure 56. Asia Pacific Interferon Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Interferon Biosimilar Sales Market Share by Region in 2019
Figure 58. Asia Pacific Interferon Biosimilar Revenue Market Share by Region in 2019
Figure 59. China Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 60. China Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 62. Japan Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 64. South Korea Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 66. India Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 68. Australia Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 70. Taiwan Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 72. Indonesia Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 74. Thailand Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 76. Malaysia Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 78. Philippines Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 80. Vietnam Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Interferon Biosimilar Market Share by Type in 2019
Figure 82. Asia Pacific Interferon Biosimilar Market Share by Application in 2019
Figure 83. Latin America Interferon Biosimilar Sales Growth Rate 2015-2020 (Kiloton)
Figure 84. Latin America Interferon Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Interferon Biosimilar Sales Market Share by Country in 2019
Figure 86. Latin America Interferon Biosimilar Revenue Market Share by Country in 2019
Figure 87. Mexico Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 88. Mexico Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 90. Brazil Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 92. Argentina Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Interferon Biosimilar Market Share by Type in 2019
Figure 94. Latin America Interferon Biosimilar Market Share by Application in 2019
Figure 95. Middle East and Africa Interferon Biosimilar Sales Growth Rate 2015-2020 (Kiloton)
Figure 96. Middle East and Africa Interferon Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Interferon Biosimilar Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Interferon Biosimilar Revenue Market Share by Country in 2019
Figure 99. Turkey Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 100. Turkey Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 102. Saudi Arabia Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Interferon Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 104. UAE Interferon Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Interferon Biosimilar Market Share by Type in 2019
Figure 106. Middle East and Africa Interferon Biosimilar Market Share by Application in 2019
Figure 107. North America Interferon Biosimilar Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 108. North America Interferon Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Interferon Biosimilar Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 110. Europe Interferon Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Interferon Biosimilar Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 112. Asia Pacific Interferon Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Interferon Biosimilar Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 114. Latin America Interferon Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Interferon Biosimilar Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 116. Middle East and Africa Interferon Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed


【掲載企業】

Roche、Biosidus、Zydus Cadila、Nanogen、Amega Biotech、Rhein Minapharm Biogenetics、PROBIOMED、3sbio、Amgen、Bayer、Schering Plough、Merck

★調査レポート[世界のインターフェロンバイオシミラー市場インサイト及び予測(~2026年)] (コード:QYR20NV01774)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のインターフェロンバイオシミラー市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆